TabletsTablets
Schedule H1 (Prescription Required - Habit Forming Warning)Anxiolytics & SedativesCode: 1901

Alprazolam 0.5mg + Sertraline Hydrochloride 25mg Tablets

Generic Formulation:Alprazolam 0.5mg and Sertraline Hydrochloride 25mg Tablets
Pack Size:10's
Common Commercial Brand Equivalents:Market reference only
Jan Aushadhi MRP
₹23.44
Brand Estimate*
₹79.9
Estimated Savings:₹56.46 (71% saved)
Find a Kendra Near You
*Statutory price across 21,118 listed Kendras
Clinical InformationReport Error

Clinical Overview

Alprazolam and Sertraline pairs an immediate-acting high-potency benzodiazepine with an SSRI. Alprazolam bridges the initial 2-4 week lag phase of antidepressant therapy by rapidly controlling severe anxiety, panicky distress, and insomnia, while sertraline elevates synaptic serotonin to alleviate core depressive illness. Indicated for major depressive episodes accompanied by prominent anxiety symptoms.

AI-assistedClinical summary synthesized from pharmacopoeial references (CDSCO, WHO EML, IP/BP/USP). Not clinician-reviewed. Drug code 1901.Report inaccuracy

Usage Guidelines

Take orally once daily, usually in the morning or evening as prescribed, with or without meals. Swallow whole. Follow precise dosage titration instructions.

General Administration Advice: Adhere strictly to the prescribed dosage, frequency, and treatment course. For oral medications, swallow with sufficient water. Never stop antibiotics, psychiatric medications, or antihypertensives abruptly without clinical direction.

Possible Side Effects

Common: Drowsiness, diarrhea, nausea, dizziness, insomnia, dry mouth, decreased libido. Rare/Severe: Serotonin syndrome, QT prolongation, paradoxical agitation, and withdrawal convulsions upon abrupt cessation.

*Note: Individual physiological responses vary. While many patients experience few or no side effects, notify your treating physician if adverse reactions persist or if hypersensitivity (angioedema, skin rash, dyspnea) occurs.

Precautions & Warnings

Contraindicated with MAOIs. Black box warnings for suicidality and physical dependence. Strict monitoring required during treatment initiation.

Schedule H1 (Prescription Required - Habit Forming Warning)

This medication is scheduled under statutory drug regulatory frameworks (CDSCO / Drugs & Cosmetics Rules). Dispensing requires a valid medical prescription from a registered medical practitioner. Self-medication or unsupervised dosage adjustment carries significant clinical risks.

Medical Disclaimer: Statutory Clinical Disclaimer: The information provided is for educational and price-transparency purposes only and does not constitute medical advice, clinical diagnosis, or treatment recommendations. Always consult a registered medical practitioner or qualified pharmacist before initiating, modifying, or substituting any medication regimen.